Hepatitis C virus alternate reading frame protein decreases interferon‑α secretion in peripheral blood mononuclear cells

Xu,Xiaodong; Yu,Xiaojie; Deng,Xiaozhao; Yue,Ming; Zhang,Jinhai; Zhu,Danyan; Zhou,Zhenxian; Zhai,Xiangjun; Xu,Ke; Zhang,Yun

doi:10.3892/mmr.2013.1816

2014-February Volume 9 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

2014-February Volume 9 Issue 2

Full Size Image

Article

Hepatitis C virus alternate reading frame protein decreases interferon‑α secretion in peripheral blood mononuclear cells

Authors:
- Xiaodong Xu
- Xiaojie Yu
- Xiaozhao Deng
- Ming Yue
- Jinhai Zhang
- Danyan Zhu
- Zhenxian Zhou
- Xiangjun Zhai
- Ke Xu
- Yun Zhang
View Affiliations / Copyright

Affiliations: Department of Biochemistry and Molecular Biology, School of Basic Medicine, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China, School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu 210009, P.R. China, Huadong Research Institute for Medicine and Biotechnics, Nanjing, Jiangsu 210002, P.R. China, Department of Clinical Laboratory, Nanjing Second Hospital, Nanjing, Jiangsu 210003, P.R. China, Department of Acute Infectious Disease Control and Prevention, Jiangsu Province Center for Disease Prevention and Control, Nanjing, Jiangsu 210009, P.R. China
Pages: 730-736
|
Published online on: November 20, 2013

https://doi.org/10.3892/mmr.2013.1816
Expand metrics +

Abstract

The hepatitis C virus (HCV) alternate reading frame protein (ARFP or F protein) of the HCV 1b genotype is a double‑frameshift product of the HCV core protein (Core). The discovery of HCV F protein challenges various biological functions attributed to Core. However, the specific characteristics of the host cellular immune response to F protein during HCV infection have yet to be fully elucidated. Therefore, the present study investigated the cytokine response to HCV Core or F protein in peripheral blood mononuclear cells (PBMCs) and plasmacytoid dendritic cells (PDCs) from patients with chronic HCV and healthy donors in vitro. The results demonstrated that the levels of interferon (IFN)‑α, analyzed by an enzyme‑linked immunosorbent assay, secreted by PBMCs in patients positive for the anti‑F protein antibody, were lower than those of patients negative for the anti‑F protein antibody. Moreover, the frequency of PDCs in patients negative for the anti‑F protein antibody, were higher than in the group positive for the anti‑F protein antibody. Furthermore, HCV F protein and Core not only inhibited specific unmethylated CpG oligonucleotide sequences of type A (CpG‑A)‑induced IFN‑α production by PBMCs and PDCs, but also upregulated the production of interleukin (IL)‑10 by PBMCs in patients with chronic HCV and healthy controls. Notably, following neutralization of IL‑10 in the media and in vitro Core or F protein stimulation, levels of IFN‑α were increased. Moreover, the results revealed that the roles of F protein and Core were similar with regard to the induction of apoptosis of PDCs in patients with chronic HCV. These findings suggest that F protein may inhibit PBMC IFN‑α secretion by regulating the production of IL‑10, and may contribute to an increase in the rates of apoptosis in PDCs. In conclusion, the results have revealed a potential involvement of F protein in the mechanisms of chronic hepatitis C.

View Figures

View References

1	Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW and Houghton M: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:359–362. 1989. View Article : Google Scholar
2	Giannini C and Bréchot C: Hepatitis C virus biology. Cell Death Differ. 10(Suppl 1): S27–S38. 2003. View Article : Google Scholar
3	Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J and Urdea MS: Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of NS-5 region. J Gen Virol. 74:2391–2399. 1993. View Article : Google Scholar : PubMed/NCBI
4	Simmonds P, Bukh J, Combet C, et al: Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology. 42:962–973. 2005. View Article : Google Scholar : PubMed/NCBI
5	Büchen-Osmond C: ICTVdB - The Universal Virus Database Version 4. Colombia University; New York, NY: 2004
6	Reed KE and Rice CM: Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Current Topics in Microbiology and Immunology: The Hepatitis C Viruses. Hagedorn CH and Rice CM: Springer; Heidelberg: pp. 55–84. 2000, PubMed/NCBI
7	Walewski JL, Keller TR, Stump DD and Branch AD: Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. RNA. 7:710–721. 2001. View Article : Google Scholar : PubMed/NCBI
8	Xu Z, Choi J, Yen TS, et al: Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J. 20:3840–3848. 2001. View Article : Google Scholar : PubMed/NCBI
9	Boulant S, Becchi M, Penin F and Lavergne JP: Unusual multiple recoding events leading to alternative forms of hepatitis C virus core protein from genotype 1b. J Biol Chem. 278:45785–45792. 2003. View Article : Google Scholar : PubMed/NCBI
10	Branch AD, Stump DD, Gutierrez JA, Eng F and Walewski JL: The hepatitis C virus alternate reading frame (ARF) and its family of novel products: the alternate reading frame protein/F-protein, the double-frameshift protein, and others. Semin Liver Dis. 25:105–117. 2005. View Article : Google Scholar
11	Vassilaki N and Mavromara P: The HCV ARFP/F/core+1 protein: production and functional analysis of an unconventional viral product. IUBMB Life. 61:739–752. 2009.
12	Marusawa H, Hijikata M, Chiba T and Shimotohno K: Hepatitis C virus core protein inhibits Fas-and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J Virol. 73:4713–4720. 1999.PubMed/NCBI
13	Ray RB, Meyer K and Ray R: Suppression of apoptotic cell death by hepatitis C virus core protein. Virology. 226:176–182. 1996. View Article : Google Scholar : PubMed/NCBI
14	Vassilaki N, Friebe P, Meuleman P, et al: Role of the hepatitis C virus core+1 open reading frame and core cis-acting RNA elements in viral RNA translation and replication. J Virol. 82:11503–11515. 2008.
15	Basu A, Steele R, Ray R and Ray RB: Functional properties of a 16 kDa protein translated from an alternative open reading frame of the core-encoding genomic region of hepatitis C virus. J Gen Virol. 85:2299–2306. 2004. View Article : Google Scholar : PubMed/NCBI
16	Ray RB, Steele R, Meyer K and Ray R: Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity. Gene. 208:331–336. 1998. View Article : Google Scholar : PubMed/NCBI
17	Kong J, Deng X, Wang Z, Yang J, Zhang Y and Yu J: Hepatitis C virus F protein: A double-edged sword in the potential contribution of chronic inflammation to carcinogenesis. Mol Med Rep. 2:461–469. 2009.PubMed/NCBI
18	Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB and Oldstone MB: Interleukin-10 determines viral clearance or persistence in vivo. Nat Med. 12:1301–1309. 2006. View Article : Google Scholar : PubMed/NCBI
19	Di Bisceglie AM and Hoofnagle JH: Optimal therapy of hepatitis C. Hepatology. 36(5 Suppl 1): S121–S127. 2002.PubMed/NCBI
20	Anthony DD, Yonkers NL, Post AB, et al: Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection. J Immunol. 172:4907–4916. 2004. View Article : Google Scholar : PubMed/NCBI
21	Goutagny N, Vieux C, Decullier E, et al: Quantification and functional analysis of plasmacytoid dendritic cells in patients with chronic hepatitis C virus infection. J Infect Dis. 189:1646–1655. 2004. View Article : Google Scholar : PubMed/NCBI
22	Dolganiuc A, Chang S, Kodys K, et al: Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. J Immunol. 177:6758–6768. 2006. View Article : Google Scholar : PubMed/NCBI
23	Yue M, Deng X, Zhai X, et al: Th1 and Th2 cytokine profiles induced by hepatitis C virus F protein in peripheral blood mononuclear cells from chronic hepatitis C patients. Immunol Lett. 152:89–95. 2013. View Article : Google Scholar : PubMed/NCBI
24	Kalamvoki M, Georgopoulou U and Mavromara P: The NS5A protein of the hepatitis C virus genotype 1a is cleaved by caspases to produce C-terminal-truncated forms of the protein that reside mainly in the cytosol. J Biol Chem. 281:13449–13462. 2006. View Article : Google Scholar : PubMed/NCBI
25	Amjad M, Abdel-Haq N, Faisal M, Kamal M and Moudgal V: Decreased interferon-alpha production and impaired regulatory function of plasmacytoid dendritic cells induced by the hepatitis C virus NS 5 protein. Microbiol Immunol. 52:499–507. 2008. View Article : Google Scholar
26	Krug A, Rothenfusser S, Hornung V, et al: Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur J Immunol. 31:2154–2163. 2001. View Article : Google Scholar : PubMed/NCBI
27	Landmann R, Knopf HP, Link S, Sansano S, Schumann R and Zimmerli W: Human monocyte CD14 is upregulated by lipopolysaccharide. Infect Immun. 64:1762–1769. 1996.PubMed/NCBI
28	Shao SW, Wu WB, Bian ZQ, et al: Hepatitis C virus F protein inhibits cell apoptosis by activation of intracellular NF-kappa-B pathway. Hepatol Res. 39:282–289. 2009. View Article : Google Scholar : PubMed/NCBI
29	Komurian-Pradel F, Rajoharison A, Berland JL, et al: Antigenic relevance of F protein in chronic hepatitis C virus infection. Hepatology. 40:900–909. 2004. View Article : Google Scholar : PubMed/NCBI
30	Colonna M, Trinchieri G and Liu YJ: Plasmacytoid dendritic cells in immunity. Nat Immunol. 5:1219–1226. 2004. View Article : Google Scholar
31	Shoukry NH, Cawthon AG and Walker CM: Cell-mediated immunity and the outcome of hepatitis C virus infection. Annu Rev Microbiol. 58:391–424. 2004. View Article : Google Scholar : PubMed/NCBI
32	Barrett L, Gallant M, Howley C, et al: Enhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individuals. BMC Immunol. 9:282008. View Article : Google Scholar
33	Siavoshian S, Abraham JD, Thumann C, Kieny MP and Schuster C: Hepatitis C virus core, NS3, NS5A, NS5B proteins induce apoptosis in mature dendritic cells. J Med Virol. 75:402–411. 2005. View Article : Google Scholar : PubMed/NCBI
34	De Vries JE and Malefyt RDW: Interleukin-10. RG Landes Co; Austin, TX: 1995
35	Martin-Blondel G, Gales A, Bernad J, et al: Low interleukin-10 production by monocytes of patients with a self-limiting hepatitis C virus infection. J Viral Hepat. 16:485–491. 2009. View Article : Google Scholar : PubMed/NCBI
36	Palucka K and Banchereau J: Dendritic cells: a link between innate and adaptive immunity. J Clin Immunol. 19:12–25. 1999. View Article : Google Scholar : PubMed/NCBI
37	Banchereau J, Briere F, Caux C, et al: Immunobiology of dendritic cells. Annu Rev Immunol. 18:767–811. 2000. View Article : Google Scholar
38	Pulendran B, Banchereau J, Maraskovsky E and Maliszewski C: Modulating the immune response with dendritic cells and their growth factors. Trends Immunol. 22:41–47. 2001. View Article : Google Scholar : PubMed/NCBI
39	Lozach PY, Lortat-Jacob H, de Lacroix de Lavalette A, et al: DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J Biol Chem. 278:20358–20366. 2003. View Article : Google Scholar : PubMed/NCBI
40	Geijtenbeek TB, Torensma R, van Vliet SJ, et al: Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell. 100:575–585. 2000. View Article : Google Scholar : PubMed/NCBI